Question map
With reference to monoclonal antibodies, often mentioned in news, consider the following statements : I. They are man-made proteins. II. They stimulate immunological function due to their ability to bind to specific antigens. III. They are used in treating viral infections like that of Nipah virus. Which of the statements given above are correct?
Explanation
All three statements about monoclonal antibodies are correct. Statement I is accurate as monoclonal antibodies are indeed man-made (laboratory-produced) proteins, derived through techniques like isolating them from peripheral blood mononuclear cells (PBMCs) of human convalescent[1] donors or survivors[2]. Statement II is correct because monoclonal antibodies target specific antigens (like viral glycoproteins)[3], which enables their therapeutic immunological function. Statement III is also valid as monoclonal antibodies isolated from Nipah virus survivors are tested for activity against Nipah virus and related viruses like Hendra virus[4], and such antibodies have demonstrated potent neutralization and therapeutic treatment capability against Nipah virus [5]infection in nonhuman primates[5]. Therefore, option D (I, II and III) is the correct answer.
Sources- [1] https://qfastr.hms.harvard.edu/qfr/antibody-based-therapeutics-against-nipah-virus
- [2] https://qfastr.hms.harvard.edu/qfr/antibody-based-therapeutics-against-nipah-virus
- [3] https://www.nature.com/articles/s41573-022-00495-3
- [4] https://qfastr.hms.harvard.edu/qfr/antibody-based-therapeutics-against-nipah-virus
- [5] https://www.nature.com/articles/s41467-024-51066-6
PROVENANCE & STUDY PATTERN
Guest previewThis is a classic 'News-to-Concept' bridge. The Nipah virus outbreaks (Kerala) and COVID-19 antibody cocktails kept 'Monoclonal Antibodies' in the headlines. The strategy is simple: When a disease dominates the news, do not just study the virus; study the *experimental therapeutics* (mAbs, mRNA, vectors) mentioned in the 'Science' section of newspapers.
This question can be broken into the following sub-statements. Tap a statement sentence to jump into its detailed analysis.
- Statement 1: With reference to monoclonal antibodies, are monoclonal antibodies man-made proteins?
- Statement 2: With reference to monoclonal antibodies, do monoclonal antibodies stimulate immune function by binding to specific antigens?
- Statement 3: With reference to monoclonal antibodies, are monoclonal antibodies used in treating viral infections such as Nipah virus infection?
- Describes isolating monoclonal antibodies from the peripheral blood mononuclear cells (PBMCs) of human convalescent donors, showing mAbs are biological antibody molecules that can be obtained and manipulated.
- States antibody isolation, testing and structural studies to identify antiviral monoclonal antibodies for use in cocktails, implying laboratory production/use as therapeutics.
- Notes that more than 20 mAbs targeting the viral S glycoprotein originated from the B cells of convalescent patients or from immunization of humanized mice, indicating mAbs can be derived and produced for clinical testing.
- Mentions these mAbs have been tested in clinical trials and some received emergency use authorization, supporting that they are developed/produced as therapeutic agents.
- Uses the term 'immunoglobulin A ... monoclonal antibodies,' explicitly identifying monoclonal antibodies as immunoglobulins, i.e., antibody molecules.
- Connecting 'immunoglobulin' terminology to monoclonal antibodies supports that these are antibody molecules (proteins) of defined specificity.
States that a gene (DNA) provides information for making a specific protein â establishes proteins are cellular products encoded by genes.
A student could combine this with the fact that antibodies are proteins and then ask whether monoclonal antibodies originate from natural cellular protein synthesis or from laboratory-directed gene/cell methods.
Reinforces that DNA in cells is the information source for making proteins and that changes in information alter the proteins produced.
One could extend this to consider whether monoclonal antibody production involves directing cells (or their DNA) to produce specific antibody proteins artificially.
Explains that medical products (vaccines) can be made in different ways, including newer approaches that instruct our own body cells â illustrates that biomedical agents can be produced or engineered.
Use this as an example that some therapeutic proteins can be produced or engineered by medical/biotech methods, prompting investigation of how monoclonal antibodies are manufactured.
Defines 'man-made' (cultural) environment as creations of humans, giving a clear conceptual distinction between natural biological products and human-made products.
A student can apply this distinction to ask whether monoclonal antibodies are natural products isolated from organisms or human-created/engineered products (thus 'man-made').
This statement analysis shows book citations, web sources and indirect clues. The first statement (S1) is open for preview.
Login with Google to unlock all statements.
This statement analysis shows book citations, web sources and indirect clues. The first statement (S1) is open for preview.
Login with Google to unlock all statements.
This tab shows concrete study steps: what to underline in books, how to map current affairs, and how to prepare for similar questions.
Login with Google to unlock study guidance.
Discover the small, exam-centric ideas hidden in this question and where they appear in your books and notes.
Login with Google to unlock micro-concepts.
Access hidden traps, elimination shortcuts, and Mains connections that give you an edge on every question.
Login with Google to unlock The Vault.